Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Apogenix Gmbh patents

Recent patent applications related to Apogenix Gmbh. Apogenix Gmbh is listed as an Agent/Assignee. Note: Apogenix Gmbh may have other listings under different names/spellings. We're not affiliated with Apogenix Gmbh, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Apogenix Gmbh-related inventors

Shortened cd95-fc variants

The present invention relates to an isolated fusion protein comprising an extracellular cd95 domain or a functional fragment thereof and an fc domain or functional fragment thereof, formulations providing such fusion protein in a stable form as well as a method for producing such a fusion protein.. . ... Apogenix Gmbh

Single-chain cd40-receptor agonist proteins

Provided herein are specific cd40 receptor agonist proteins, nucleic acids encoding the same, and methods of treating a subject having a cd40l-associated disease or disorder. The cd40 receptor agonist proteins provided herein comprise three soluble cd40l domains and an fc fragment. ... Apogenix Gmbh

Inhibitors of the cd95 signaling pathway for treatment of mds

The present invention relates to inhibitors of the cd95 signaling pathway for the use in the treatment of myelodysplastic syndrom (mds) wherein the mds is selected from the ipss low risk mds subgroup and/or the ipss intermediate-1 (int-1) risk mds subgroup as well as a method for the diagnosis of mds.. . ... Apogenix Gmbh

Combination of cd95/cd95l inhibition and cancer immunotherapy

The present invention relates to the treatment of cancer using a combination of an inhibitor of the cd95/cd95l signaling system and an immunotherapeutic agent, e.g. A cancer vaccine or a checkpoint inhibitor. ... Apogenix Gmbh

Gitrl collectin fusion proteins

The present invention refers to a fusion protein comprising a tnf-superfamily (tnfsf) cytokine or a receptor binding domain thereof fused to a collectin trimerization domain, to a nucleic acid molecule encoding the fusion protein, and to a cell comprising the nucleic acid molecule. The fusion protein is present as a trimeric complex or as an oligomer thereof. ... Apogenix Gmbh

Single-chain fusion polypeptide comprising trail

The present invention refers to single-chain fusion proteins comprising three soluble tnf superfamily (tnfsf) cytokine domains and nucleic acid molecules encoding these fusion proteins. The fusion proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications.. ... Apogenix Gmbh

Diagnostic anti-cd95l antibody

The present invention relates to a specific cd95l antibody and to the use thereof in the diagnosis of a cancer disease.. . ... Apogenix Gmbh

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Apogenix Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Apogenix Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by